INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/08/2026
Voltar para busca
Dado oficial do USPTO
V-CRT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
09/08/2026
Tipo de marca
Verbal
Classes Nice
5, 39, 42
Data de depósito
27/02/2017
Data de registro
05/02/2019
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Ravensburg, DE
Examinador
DONEGAN, DANIEL P
Localização atual
Historical data usage
Titulares e representantes
Titulares
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 39Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Aseptically manufactured pharmaceutical preparations and drugsorally administrable solutionsinjectable solutionssolids and semisolids capable of being dissolved in liquids and solventspowders in ready-to-use form or capable of reconstitutionall for use in the treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial dysfunctionliver dysfunctionoral and laryngeal diseaseoptical and cranial disorders; pharmaceutical solutions to be taken orallysterile aseptic solutions and injection solutions in forms suitable for sale and applicationpharmaceutical solutionssterile aseptic solutions and injection solutions all for use in the treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial dysfunctionliver dysfunctionlaryngeal diseaseoptical and cranial disorders; swabs for medical purposesnon-impregnated cotton swabspremoistened cotton swabs and cotton swabs impregnated with alcoholiodinesterilizing agents and cleaning solutions for medical purposes
Classe 39
Asepticsterile bottling of substances
Classe 42
Scientific and technical development of injection syringes and instrumentsinjectors and related packaging; chemicalphysical and process engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
09/12/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
09/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/12/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
05/08/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/05/2019
FIMP
FINAL DISPOSITION PROCESSED
31/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/02/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/02/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/01/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
16/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/11/2018
PUBO
PUBLISHED FOR OPPOSITION
20/11/2018
GPNX
NOTIFICATION PROCESSED BY IB
16/11/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
31/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/10/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2018
ALIE
ASSIGNED TO LIE
10/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/09/2018
RFNP
REFUSAL PROCESSED BY IB
19/05/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/03/2018
GNRT
NON-FINAL ACTION E-MAILED
27/03/2018
CNRT
NON-FINAL ACTION WRITTEN
27/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/02/2018
RFNP
REFUSAL PROCESSED BY IB
09/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/08/2017
RFRR
REFUSAL PROCESSED BY MPU
23/08/2017
MAFR
APPLICATION FILING RECEIPT MAILED
22/08/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/08/2017
CNRT
NON-FINAL ACTION WRITTEN
18/08/2017
DOCK
ASSIGNED TO EXAMINER
16/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace V-CRT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.